LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

Photo from wikipedia

Abstract The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused the ongoing pandemic named COVID‐19 which causes a serious emergency on public health hazards of international concern. In the… Click to show full abstract

Abstract The novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) caused the ongoing pandemic named COVID‐19 which causes a serious emergency on public health hazards of international concern. In the face of a critical medical emergency, repositioning of drugs is one of the most authentic options to design an adequate treatment for infected patients immediately. In this strategy, Remdesivir (Veklury), Hydroxychloroquine appears to be the drug of choice and garnered unprecedented attention as potential therapeutic agents against the pandemic realized worldwide due to SARS‐CoV‐2 infection. These are the breathtaking instances of possible repositioning of drugs, whose pharmacokinetics and optimal dosage are familiar. In this review, we provide an overview of these medications, their synthesis, and the possible mechanism of action against SARS‐CoV‐2.

Keywords: severe acute; syndrome coronavirus; coronavirus sars; sars cov; acute respiratory; respiratory syndrome

Journal Title: Journal of Heterocyclic Chemistry
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.